Abstract: Genome-wide association studies (GWAS) identified the chromosome 15q25.1 locus as a leading susceptibility region for lung cancer. However, the pathogenic pathways, through which susceptibility SNPs within chromosome 15q25.1 affects lung cancer risk, have not been explored. We analyzed three cohorts with GWAS data consisting 42,901 individuals and lung expression quantitative trait loci (eQTL) data on 409 individuals to identify and validate the underlying pathways and to investigate the combined effect of genes from the identified susceptibility pathways. The KEGG neuroactive ligand receptor interaction pathway, two Reactome pathways, and 22 Gene Ontology terms were identified and replicated to be significantly associated with lung cancer risk, with P values less than 0.05 and FDR less than 0.1. Functional annotation of eQTL analysis results showed that the neuroactive ligand receptor interaction pathway and gated channel activity were involved in lung cancer risk. These pathways provide important insights for the etiology of lung cancer.
Introduction
Genome-wide association studies (GWAS) have long identified chromosome 15q25.1 as a major susceptibility locus for lung cancer, nicotine addiction, and smoking behavior. However, identifying a location on a chromosome is not the same as understanding a biological process. While the chromosome 15q25.1 region is the most well-known genetic "hotspot" for lung cancer risk, the biological mechanisms behind this association have remained elusive.
The challenge is that common single-nucleotide polymorphisms (SNPs) usually have very small individual effects. Lung cancer is a complex disease likely driven by the aggregate effect of multiple variants working within shared biological pathways. This study moves beyond single-gene analysis to identify specific susceptibility pathways—most notably neuroactive ligand-receptor interaction and gated channel activity—that drive this risk through complex gene-gene interactions and altered gene expression in lung tissue.
Methods
The researchers employed a multi-stage analytical pipeline to move from broad genomic regions to specific functional pathways. The process involved primary GWAS analysis, index SNP selection, epistasis screening, and pathway enrichment using an improved Gene Set Enrichment Analysis (i-GSEA4GWAS) approach to identify biological pathways (from KEGG, Reactome, and Gene Ontology) overrepresented among interacting SNPs.
Findings were validated using a massive independent replication cohort and functional validation via expression quantitative trait loci (eQTL) data from human lung tissues. This allowed the team to see if these genetic variants actually influenced how genes are expressed (turned "on" or "off") in the lung.
Datasets
The study leveraged several large-scale datasets totaling over 42,000 individuals:
- Discovery Cohort 1 (EAGLE): 1,923 lung cancer cases and 1,977 controls of Italian origin.
- Discovery Cohort 2 (MDACC & IARC): 2,995 cases and 3,578 controls of European ancestry.
- Replication Cohort (Oncoarray): A massive set of 18,439 cases and 14,026 controls.
- Lung eQTL Data (Laval University): Gene expression data from non-cancerous lung tissue of 409 patients to validate functional impacts.
Key Insights and Ideas
- The "Neuroactive" Connection: The most significant finding was the KEGG neuroactive ligand-receptor interaction pathway. While often associated with brain function, many of these receptors (like nicotinic acetylcholine receptors CHRNA3 and CHRNB4) are expressed in lung tissue and are critical for signaling that can lead to malignancy.
- Beyond Smoking: While 15q25.1 is heavily linked to smoking behavior, the study found that these pathways contribute to lung cancer risk both through smoking-related mechanisms and potentially through direct effects on lung tissue biology.
- The Power of Interaction: The study highlights that the "missing heritability" in cancer often lies in epistasis (SNP-SNP interactions). Variants that seem insignificant on their own become highly relevant when their interactions with the 15q25.1 locus are considered.
- Dose-Response Effect: The risk is cumulative. The more risk alleles an individual carries within these specific pathways, the higher their odds of developing lung cancer.
Key Results
The KEGG neuroactive ligand-receptor interaction pathway, two Reactome pathways, and 22 Gene Ontology (GO) terms were significantly associated with lung cancer risk (P < 0.05, FDR < 0.1). In the neuroactive pathway, individuals carrying four risk alleles had a >2-fold increased risk of lung cancer compared to those with zero or one (OR = 2.07 in discovery; OR = 1.74 in replication).
The "gated channel activity" GO term was also strongly validated in the eQTL analysis (P = 0.029), suggesting that ion transport and cellular signaling are core components of the 15q25.1-mediated risk. Key genes driving these associations included CHRNA3, CHRNB4, KCNJ4, and SCN2B.
Limitations and Future Work
The study focused almost exclusively on populations of European ancestry, meaning results may not be globally generalizable. Additionally, the association in never-smokers did not reach genome-wide significance in the discovery phase, leaving pathways for non-smoking-related lung cancer less clear. While the study identifies which pathways are involved, future work involving protein-protein interaction data and granular functional "wet lab" studies will be needed to pinpoint exactly how these gated channels and receptors trigger oncogenesis.
Summary updated